Target intelligence / Profile preview

Programmed cell death protein 7 (PDCD7)

Target
PDCD7
Molecular classification
Other, U11/U12 small nuclear ribonucleoprotein component, Splicing factor, Component of minor spliceosome
01

Overview

Programmed cell death protein 7 is a 59 kDa nuclear protein encoded by the PDCD7 gene. It is associated with the U11 small nuclear ribonucleoprotein (snRNP), a component of the minor U12-type spliceosome that is responsible for the splicing of U12-type introns in pre-mRNA. PDCD7 promotes apoptosis when overexpressed and plays a role in specific apoptotic processes in T-cells, and is also implicated in RNA splicing. Studies in mouse T-cells indicate involvement in apoptotic pathways related to glucocorticoids, staurosporine, and ceramide-mediated signaling. It is not considered a druggable therapeutic target (e.g., receptor, enzyme, transporter, or transcription factor), but rather as a component of the splicing machinery. It is not currently established as a therapeutic target and primarily functions as a component of the minor spliceosome in eukaryotic cells. There is limited evidence implicating PDCD7 directly as a disease-driving gene or direct therapeutic target in common disease categories; it is not a drug target nor is it known to interact with approved drugs. No known biomarkers for patient selection or monitoring, no interacting drugs, and no documented safety concerns as a direct therapeutic target.

Other names
hES18HES18ES1859KU11/U12 snRNP 59Kapoptosis-related protein ES18
02

Biological functions

ApoptosisPre-mRNA splicingCell deathRNA processing
03

Disease associations

No strong evidence as a drug target in major disease categories

Beyond the preview

Go deeper on Programmed cell death protein 7 (PDCD7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Programmed cell death protein 7 (PDCD7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call